Works matching IS 09509232 AND DT 2011 AND VI 30 AND IP 36

Results: 7

Interstitial lung disease induced by gefitinib and Toll-like receptor ligands is mediated by Fra-1.

Published in:

Oncogene, 2011, v. 30, n. 36, p. 3821, doi. 10.1038/onc.2011.101

By:

Takada, Y;
Gresh, L;
Bozec, A;
Ikeda, E;
Kamiya, K;
Watanabe, M;
Kobayashi, K;
Asano, K;
Toyama, Y;
Wagner, E F;
Matsuo, K

Publication type:

Article

Pleiotropic regulation of macrophage polarization and tumorigenesis by formyl peptide receptor-2.

Published in:

Oncogene, 2011, v. 30, n. 36, p. 3887, doi. 10.1038/onc.2011.112

By:

Li, Y;
Cai, L;
Wang, H;
Wu, P;
Gu, W;
Chen, Y;
Hao, H;
Tang, K;
Yi, P;
Liu, M;
Miao, S;
Ye, D

Publication type:

Article

Loss of AF6/afadin, a marker of poor outcome in breast cancer, induces cell migration, invasiveness and tumor growth.

Published in:

Oncogene, 2011, v. 30, n. 36, p. 3862, doi. 10.1038/onc.2011.106

By:

Fournier, G;
Cabaud, O;
Josselin, E;
Chaix, A;
Adélaïde, J;
Isnardon, D;
Restouin, A;
Castellano, R;
Dubreuil, P;
Chaffanet, M;
Birnbaum, D;
Lopez, M

Publication type:

Article

ARF1 controls proliferation of breast cancer cells by regulating the retinoblastoma protein.

Published in:

Oncogene, 2011, v. 30, n. 36, p. 3846, doi. 10.1038/onc.2011.100

By:

Boulay, P-L;
Schlienger, S;
Lewis-Saravalli, S;
Vitale, N;
Ferbeyre, G;
Claing, A

Publication type:

Article

Wwox inactivation enhances mammary tumorigenesis.

Published in:

Oncogene, 2011, v. 30, n. 36, p. 3900, doi. 10.1038/onc.2011.115

By:

Abdeen, S K;
Salah, Z;
Maly, B;
Smith, Y;
Tufail, R;
Abu-Odeh, M;
Zanesi, N;
Croce, C M;
Nawaz, Z;
Aqeilan, R I

Publication type:

Article

Upregulation of miR-27a contributes to the malignant transformation of human bronchial epithelial cells induced by SV40 small T antigen.

Published in:

Oncogene, 2011, v. 30, n. 36, p. 3875, doi. 10.1038/onc.2011.103

By:

Wang, Q;
Li, D-C;
Li, Z-F;
Liu, C-X;
Xiao, Y-M;
Zhang, B;
Li, X-D;
Zhao, J;
Chen, L-P;
Xing, X-M;
Tang, S-F;
Lin, Y-C;
Lai, Y-D;
Yang, P;
Zeng, J-L;
Xiao, Q;
Zeng, X-W;
Lin, Z-N;
Zhuang, Z-X;
Zhuang, S-M

Publication type:

Article

NANOG promotes cancer stem cell characteristics and prostate cancer resistance to androgen deprivation.

Published in:

Oncogene, 2011, v. 30, n. 36, p. 3833, doi. 10.1038/onc.2011.114

By:

Jeter, C R;
Liu, B;
Liu, X;
Chen, X;
Liu, C;
Calhoun-Davis, T;
Repass, J;
Zaehres, H;
Shen, J J;
Tang, D G

Publication type:

Article